Kraj: Unia Europejska
Język: angielski
Źródło: EMA (European Medicines Agency)
Ribavirin
Teva B.V.
J05AP01
ribavirin
Antivirals for systemic use
Hepatitis C, Chronic
Ribavirin Teva Pharma B.V. is indicated in combination with other medicinal products for the treatment ofchronic hepatitis C (CHC) in adults (see sections 4.2, 4.4, and 5.1).Ribavirin Teva Pharma B.V. is indicated in combination with other medicinal products for the treatment ofchronic hepatitis C (CHC) for paediatric patients (children 3 years of age and older and adolescents) notpreviously treated and without liver decompensation (see sections 4.2, 4.4 and 5.1).
Revision: 14
Withdrawn
2009-07-01
70 B. PACKAGE LEAFLET Medicinal product no longer authorised 71 PACKAGE LEAFLET: INFORMATION FOR THE USER RIBAVIRIN TEVA PHARMA B.V. 200 MG FILM-COATED TABLETS ribavirin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET : 1. What Ribavirin Teva Pharma B.V. is and what it is used for 2. What you need to know before you use Ribavirin Teva Pharma B.V. 3. How to use Ribavirin Teva Pharma B.V. 4. Possible side effects 5. How to store Ribavirin Teva Pharma B.V. 6. Contents of the pack and other information 1. WHAT RIBAVIRIN TEVA PHARMA B.V. IS AND WHAT IT IS USED FOR Ribavirin Teva Pharma B.V. contains the active substance ribavirin. This medicine stops the multiplication of hepatitis C virus. Ribavirin Teva Pharma B.V. must not be used alone. Depending on the genotype of the hepatitis C virus that you have, your doctor may choose to treat you with a combination of this medicine with other medicines. There may be some further treatment limitations if you have or have not been previously treated for chronic hepatitis C infection. Your doctor will recommend the best course of therapy. The combination of Ribavirin Teva Pharma B.V. and other medicines is used to treat patients who have chronic hepatitis C (HCV). Ribavirin Teva Pharma B.V. may be used in paediatric patients (children 3 years of age and older and adolescents) who are not previously treated and without severe liver disease. For paediatric patients (children and adolescents) weighing less than 47 kg a solution formulation is available. If Przeczytaj cały dokument
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Medicinal product no longer authorised 2 1. NAME OF THE MEDICINAL PRODUCT Ribavirin Teva Pharma B.V. 200 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each Ribavirin Teva Pharma B.V. tablet contains 200 mg of ribavirin For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet. Light pink to pink, (debossed with “93” on one side and “7232” on the other). 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ribavirin Teva Pharma B.V. is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adults (see sections 4.2, 4.4, and 5.1). Ribavirin Teva Pharma B.V. is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CHC) for paediatric patients (children 3 years of age and older and adolescents) not previously treated and without liver decompensation (see sections 4.2, 4.4 and 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Treatment should be initiated, and monitored, by a physician experienced in the management of chronic hepatitis C. Posology Ribavirin Teva Pharma B.V. must be used in combination therapy as described in section 4.1. Please refer to the corresponding Summary of Product Characteristics (SmPC) of medicinal products used in combination with Ribavirin Teva Pharma B.V. for additional prescribing information particular to that product and for further dosage recommendations on co-administration with Ribavirin Teva Pharma B.V. Ribavirin Teva Pharma B.V. tablets are to be administered orally each day in two divided doses (morning and evening) with food. _Adults: _ The recommended dose and duration of Ribavirin Teva Pharma B.V. depends on patient’s weight and on the medicinal product that is used in combination. Please refer to the corresponding SmPC of medicinal products used in combination with Ribavirin Teva Pharma B.V. In the cases in which no specific dose recommendation is made, the following dose should Przeczytaj cały dokument